JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHU, H. I.
Right arrow Articles by HASTINGS, A. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHU, H. I.
Right arrow Articles by HASTINGS, A. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 63, Issue 4, 407-413, 1938
Copyright © 1938 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF PARA-AMINO BENZENE SULFONAMIDE ON THE OXYGEN CONSUMPTION OF TISSUE AND CERTAIN PATHOGENIC BACTERIA

H. I. CHU 1 and A. B. HASTINGS 1

1 From the Department of Biological Chemistry, Harvard Medical School, Boston

The effect of para-amino benzene sulfonamide on the oxygen consumption of rat liver and diaphragm, human blood, beta hemolytic streptococcus, gonococcus, pneumococci, types I and III, and meningococcus group I-III, was studied with the direct Warburg technique. With the exception of meningococcus, the drug at a concentration of 0.0132 gram per cent produced no effect. Increasing the drug concentration up to 0.660 gram per cent invariably reduced the oxygen uptake of the tissue as well as the bacteria. The effect of 0.132 gram per cent of the drug was variable.

Submitted on January 15, 1938







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1938 by the American Society for Pharmacology and Experimental Therapeutics.